Molecular Templates, Inc.
General ticker "MTEM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $285.4K (TTM average)
Molecular Templates, Inc. does not follow the US Stock Market performance with the rate: -24.6%.
Estimated limits based on current volatility of 0.0%: low 0.00$, high 0.00$
Factors to consider:
- US accounted for 86.9% of revenue in the fiscal year ended 2022-12-31
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.29$, 0.87$]
- 2024-12-30 to 2025-12-30 estimated range: [0.36$, 1.00$]
Financial Metrics affecting the MTEM estimates:
- Negative: Non-GAAP EPS, $ of -10.70 <= 0.04
- Negative: negative Net income
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -96.96 <= 1.76
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Shareholder equity ratio, % of 11.90 <= 22.51
- Negative: negative Industry operating income (median)
Short-term MTEM quotes
Long-term MTEM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $38.70MM | $19.75MM | $57.31MM |
| Operating Expenses | $118.77MM | $108.62MM | $67.77MM |
| Operating Income | $-80.07MM | $-88.87MM | $-10.47MM |
| Non-Operating Income | $-2.94MM | $-3.79MM | $2.33MM |
| Interest Expense | $3.37MM | $4.78MM | $2.65MM |
| R&D Expense | $84.67MM | $82.42MM | $48.88MM |
| Income(Loss) | $-83.01MM | $-92.67MM | $-8.13MM |
| Taxes | $0.00MM | $0.05MM | $-0.01MM |
| Profit(Loss)* | $-79.31MM | $-92.72MM | $-8.12MM |
| Stockholders Equity | $65.66MM | $-15.13MM | $4.21MM |
| Assets | $192.36MM | $97.55MM | $35.38MM |
| Operating Cash Flow | $-30.39MM | $-89.02MM | $-41.82MM |
| Capital expenditure | $4.00MM | $3.20MM | $0.20MM |
| Investing Cash Flow | $-62.44MM | $95.32MM | $29.09MM |
| Financing Cash Flow | $92.59MM | $-0.27MM | $-9.12MM |
| Earnings Per Share** | $-21.51 | $-24.69 | $-1.80 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.